REVB Revelation Bio Year-over-year net earnings per share growth for the last 12 months
The quarterly EPS percentage change reflects the profit dynamics of Revelation Biosciences (REVB), where 88.20 captures the value of this parameter. The company is currently undergoing a phase of intensive scientific research characterized by high biological risks. Growth potential is based on the unique Gemini drug for kidney protection, while further success depends on securing financing and the test results of allergy treatments.
Revelation Biosciences (REVB) - metric breakdowns and financial figures
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Debt to Equity Revelation Biosciences|REVB - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Revelation Biosciences Corp|REVB - Company Cumulative Debt|Debt to Book Value Revelation Biosciences|REVB - Company Long-Term Debt|Company Short-Term Debts Revelation Biosciences|Quick Liquidity revbiosciences.com
- earnings and market multiples details:
REVB - Company Net Income|Projected Future Earnings Revelation Biosciences|REVB - P/E Multiple|Projected Price to Earnings Revelation Bio|REVB - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Revelation Biosciences Inc|REVB - Operating income before deduction of amortization|Earnings per share for the last twelve months Revelation Biosciences|REVB - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months revbiosciences.com|REVB - Earnings per share growth this year|Expected earnings per share growth for next year Revelation Biosciences
- company sales and revenue statistics:
Comprehensive company analysis:Revelation Bio, REVB
The pricing power of Revelation Biosciences (REVB) within the inelastic demand segment for the Gemini drug is reflected in the quarterly growth dynamics of earnings per share. This indicator measures the percentage change in net income per common share over a quarter, allowing for an assessment of the actual efficiency of business capitalization; however, a final conclusion requires comparing this growth rate with the issuer's debt load.
Direct competitors
argenx BVBA (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech SE|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth admabiologics.com|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics Inc (PTGX)|Immunovant - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (kiniksa.com)|Grifols Group (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Inc. - Quarterly EPS earnings growth|Celldex Therapeutics (CLDX) - Year-over-year net earnings per share growth for the last 12 months|AUPH (auriniapharma.com) - Year-over-year net earnings per share growth for the last 12 months|BCRX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Vera Pharma|Quarterly EPS earnings growth Dianthus Corp|Year-over-year earnings per share growth for the last twelve months Pharvaris N.V. (PHVS)|ABCL - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Tourmaline Bio Inc TRML|Year-over-year net earnings per share change for the last twelve months Precigen (PGEN)|Pharming Corp - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months NKTR (Nektar Therapeutics)|upstreambio.com (UPB) - Year-over-year earnings per share growth for the last twelve months|ZBIO (Zenas Biopharma Inc) - Year-over-year earnings per share growth for the last twelve months|IMNM (Immunome Bio) - Quarterly EPS earnings growth|GOSS: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KALV (KalVista Pharmaceuticals Inc)|SEPN (Septerna Corp) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PVLA (Pieris Corp)|SVRA - Year-over-year net earnings per share growth for the last 12 months|RIGL - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months ANAB (AnaptysBio)|ATXS: Quarterly EPS earnings growth|ENGN - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RAPT|JBIO: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Aclaris Therapeutics (ACRS)|KYTX: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth TLSA (Tiziana Life Sciences, Ltd.)|Year-over-year net earnings per share change for the last twelve months Cabaletta Bio Inc (CABA)|ventyxbio.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months theratech.com|AVTX: Quarterly EPS earnings growth|ELDN: Year-over-year earnings per share growth rate for the last twelve months|AGEN (Agenus, Inc) - Quarterly EPS earnings growth|Climb Bio, Inc. - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Zura Bio (ZURA)|ATYR - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Adagene ADAG|Year-over-year earnings per one share growth for the last 12 months IMA|STTK: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months EQ (equilliumbio.com)|Connect Biopharma Holdings Limited (CNTB) - Year-over-year earnings per share growth for the last twelve months|Immunic, Inc. (IMUX) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months ATRA|IFRX: Year-over-year earnings per one share growth for the last 12 months|X4 Pharmaceuticals Inc. (XFOR) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months Adicet ACET|Quarterly EPS earnings growth CELU (Celularity Inc)|Quarterly EPS earnings growth INmune Bio INMB|Barinthus Biotherapeutics plc - Quarterly EPS earnings growth|Kezar Life Sciences, Inc. (KZR) - Year-over-year net earnings per share growth for the last 12 months|SAB Biotherapeutics, Inc (SABS) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Akari Therapeutics plc|Year-over-year earnings per share growth for the last twelve months enlivex.com|Earnings per share growth in annualized terms for the last twelve months q32bio.com QTTB|Year-over-year earnings per share growth for the last twelve months GeoVax Labs (GOVX)|EDSA (Edesa Biotech) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ibioinc.com IBIO|Quarterly EPS earnings growth carismatx.com CARM|XTLB - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months BOLT (boltbio.com)|HCW Biologics Inc (HCWB) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Aptevo|Year-over-year net earnings per share growth for the last 12 months AIM|Year-over-year earnings per share growth for the last 12 months ADTX (aditxt.com)|Year-over-year earnings per share growth for the last twelve months GRI Bio Inc (GRI)|XRTX (XORTX Therapeutics Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth HIND (Vyome Therapeutics)|INDP - Year-over-year net earnings per share growth for the last 12 months|SCNI: Year-over-year net earnings per share growth for the last 12 months|CALI: Year-over-year earnings per share growth for the last twelve months|AFMD: Quarterly EPS earnings growth|Allakos Inc - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months HOOKIPA Pharma, Inc.|IGM Biosciences, Inc. (IGMS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months iteostherapeutics.com (ITOS)|OCEA - Earnings per share growth in annualized terms for the last twelve months|TC BioPharm (Holdings) PLC - Year-over-year net earnings per share growth for the last 12 months|THRD: Year-over-year earnings per share growth for the last 12 months
